Tuesday, November 15, 2016
- 9:00AM-11:00AM
-
Abstract Number: 2953
Comparison of Patient Outcomes in Primary Angiitis of the Central Nervous System and Reversible Cerebral Vasoconstriction Syndrome
Vasculitis - Poster III: Rarer Vasculitides- 9:00AM-11:00AM
-
Abstract Number: 2356
Comparison of Spa Therapy with or without Physical Rehabilitation for Knee Osteoarthritis: A Randomized Controlled Trial
Osteoarthritis – Clinical Aspects - Poster II- 9:00AM-11:00AM
-
Abstract Number: 16L
Comparison of Systematic Vs Individually Tailored Rituximab Regimen to Maintain ANCA-Associated–Vasculitis Remission: Results of a Prospective, Randomized–Controlled, Phase 3 Trial
ACR Late-Breaking Poster Session- 9:00AM-11:00AM
-
Abstract Number: 2689
Comparison of the 2016 ACR/EULAR and the 2002 AECG Classification Criteria in a Cohort of Patients with Suspected Primary SjöGren’s Syndrome
Sjögren's Syndrome - Poster II: Clinical Science- 9:00AM-11:00AM
-
Abstract Number: 2802
Comparison of the Clinical, Serological, and Prognostic Differences Among Juvenile-, Adult-, and Late-Onset Lupus Nephritis in Korean Patients: A Case-Control Study
Systemic Lupus Erythematosus – Clinical Aspects and Treatment - Poster III: Biomarkers and Nephritis- 9:00AM-11:00AM
-
Abstract Number: 2589
Comparison of Two Enzyme-Linked Immunosorbent Assays Used for Drug Concentration Monitoring in Psoriatic Arthritis Patients Treated with Certolizumab Pegol
Rheumatoid Arthritis – Small Molecules, Biologics and Gene Therapy - Poster III- 9:00AM-11:00AM
-
Abstract Number: 2175
Comparisons of Patients Prescribed Biosimilars or BIO-Originators for Autoimmune Diseases in Germany
Epidemiology and Public Health - Poster III- 9:00AM-11:00AM
-
Abstract Number: 2094
Complement Activation in Antiphospholipid Syndrome Due to the Multi-Activated Pathways of the Complement System
Antiphospholipid Syndrome - Poster II- 9:00AM-11:00AM
-
Abstract Number: 2820
Comprehensive Aptamer-Based Screening of 1129 Proteins Reveals Novel Urinary Biomarkers of Lupus Nephritis
Systemic Lupus Erythematosus – Clinical Aspects and Treatment - Poster III: Biomarkers and Nephritis- 9:00AM-11:00AM
-
Abstract Number: 2195
Conceptualizing the Life Course in the Employment Experiences of Working-Aged Adults with Arthritis: A Qualitative Study
Epidemiology and Public Health - ARHP Poster- 9:00AM-11:00AM
-
Abstract Number: 2516
Concomitant Use of Oral Vs. Subcutaneous Methotrexate at Biologic Initiation: A Comparison of Biologic Treatment Survival in a Rheumatoid Arthritis Cohort
Rheumatoid Arthritis – Clinical Aspects - Poster III: Treatment – Monitoring, Outcomes, Adverse Events- 9:00AM-11:00AM
-
Abstract Number: 2750
Concordance Between Patient and Physician Global Assessment of the Disease in Patients with Psoriatic Arthritis
Spondylarthropathies and Psoriatic Arthritis – Clinical Aspects and Treatment - Poster III